565 related articles for article (PubMed ID: 18280748)
21. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T
Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858
[TBL] [Abstract][Full Text] [Related]
22. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
23. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
Zhang C; Zhang J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
[TBL] [Abstract][Full Text] [Related]
26. NKG2D and cytotoxic effector function in tumor immune surveillance.
Hayakawa Y; Smyth MJ
Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell signaling pathways.
Vivier E; Nunès JA; Vély F
Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
[TBL] [Abstract][Full Text] [Related]
28. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
29. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
[TBL] [Abstract][Full Text] [Related]
31. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy.
Zhang J; Sun R; Wei H; Zhang J; Tian Z
Haematologica; 2004 Mar; 89(3):338-47. PubMed ID: 15020274
[TBL] [Abstract][Full Text] [Related]
32. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
[TBL] [Abstract][Full Text] [Related]
33. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
34. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
35. How NKG2D ligands trigger autoimmunity?
Caillat-Zucman S
Hum Immunol; 2006 Mar; 67(3):204-7. PubMed ID: 16698443
[TBL] [Abstract][Full Text] [Related]
36. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
Vahlne G; Becker S; Brodin P; Johansson MH
Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
[TBL] [Abstract][Full Text] [Related]
37. A phenotypic and functional characterization of NK cells in adenoids.
Mizrahi S; Yefenof E; Gross M; Attal P; Ben Yaakov A; Goldman-Wohl D; Maly B; Stern N; Katz G; Gazit R; Sionov RV; Mandelboim O; Chaushu S
J Leukoc Biol; 2007 Nov; 82(5):1095-105. PubMed ID: 17675561
[TBL] [Abstract][Full Text] [Related]
38. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
[TBL] [Abstract][Full Text] [Related]
39. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.
Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR
Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]